Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs
The acquisition is Samfara’s first investment and is backed by a syndicate of European and North American institutional investors and family offices LONDON, Oct. 2, 2026 /PRNewswire/ — Samfara, a European life
